Cardioprotective potential of angiotensin converting enzyme inhibitors.
This is a brief overview of various mechanisms activated by angiotensin converting enzyme (ACE) inhibition that affect the anatomy and function of the heart. The benefits of ACE inhibition include not only a reduction in blood pressure but also improved insulin responsiveness, prevention of potassium loss, diminished myocardial oxygen demand, suppression of catecholamines, and interaction with bradykinin and prostaglandins. These benefits result in improved perfusion of vital organs, diminished cardiac work, and protection of coronary vessels, evident in improved left ventricular systolic and diastolic function, elevation of the anginal threshold in ischemic heart disease, and decreased morbidity and mortality in congestive heart failure. The cardioprotective effects of ACE inhibition have been demonstrated by numerous multicenter long-term trials.
Gavras
I
I
Department of Medicine, Boston University School of Medicine, MA 02118, USA.
Gavras
H
H
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D003327:Coronary Disease / Q000517:prevention & control; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*
D000806:Angiotensin-Converting Enzyme Inhibitors